LabMedica

Download Mobile App
Recent News Expo
ADLM 2025
Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

PerkinElmer Divests Other Businesses to Focus on Life Sciences and Diagnostics

By LabMedica International staff writers
Posted on 02 Aug 2022

PerkinElmer, Inc. (Waltham, MA; USA) has entered into an agreement with the intention to divest its Applied, Food and Enterprise Services businesses to New Mountain Capital (New York, NY, USA) for total consideration of USD 2.45 billion in cash.

The business being divested includes PerkinElmer’s leading OneSource laboratory and field services, along with a portfolio of atomic spectroscopy, molecular spectroscopy, and chromatography instruments, consumables and reagents that serve the biopharma, food, environmental & safety and applied end markets. The PerkinElmer brand will be transferred with the business, and the transaction is expected to close in the first quarter of 2023, subject to regulatory approvals and other customary closing conditions. The company’s business following the close of the transaction will consist of its Life Sciences and Diagnostics businesses.


Image: PerkinElmer is divesting its Applied, Food and Enterprise Services businesses (Photo courtesy of PerkinElmer)
Image: PerkinElmer is divesting its Applied, Food and Enterprise Services businesses (Photo courtesy of PerkinElmer)

“Today's announcement is a pivotal step in the significant portfolio transformation we have been executing on over the last several years," said Prahlad Singh, president and chief executive officer of PerkinElmer. "Following the close of the transaction, we will be a pure-play, high growth, high margin Life Sciences and Diagnostics company with unique scale. The Company’s increased financial strength will support accelerated investment into attractive end markets across science and disease, and drive advanced research, discovery, and improve global health.”

Singh continued, "This milestone has been made possible by the hard work of our nearly 17,000 employees across the globe. It is a validation of our people and the incredible businesses we have built. With this transaction, the Applied, Food and Enterprise Services businesses are gaining a partner who is committed to building on their record of success. Upon closing of the transaction, I believe both organizations will benefit significantly from increased focus and aligned investment on their unique market opportunities.”

Related Links:
PerkinElmer, Inc. 
New Mountain Capital 


New
Gold Member
Hematology Analyzer
Medonic M32B
3-Part Differential Hematology Analyzer
Swelab Alfa Plus Sampler
New
HBV DNA Test
GENERIC HBV VIRAL LOAD VER 2.0
New
Sperm Quality Analyis Kit
QwikCheck Beads Precision and Linearity Kit

Latest Industry News

PHASE Scientific and Lumos Diagnostics Partner on Rapid POC Test for Bacterial Respiratory Infection
02 Aug 2022  |   Industry

QuidelOrtho and BÜHLMANN Collaborate on Gastrointestinal Biomarker Tests
02 Aug 2022  |   Industry

BD Biosciences & Diagnostic Solutions to Merge with Waters
02 Aug 2022  |   Industry



PURITAN MEDICAL